Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05736965
Status:
RECRUITING
Last Update Posted:
2023-03-15
First Post:
2023-02-12
Brief Title:
A Study of Selinexor in Combination With Azacitidine and Venetoclax SAV Regimen in Treatment Naïve Participants With Acute Myeloid Leukemia
Sponsor:
Shanghai Tong Ren Hospital
Organization:
Shanghai Tong Ren Hospital
Organization Data
Organization:
Shanghai Tong Ren Hospital
Class:
OTHER
Study ID:
SAV
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Tong Ren Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Liu Ligen
Responsible Party Title:
Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Tong Ren Hospital
Old Name:
None
Old Organization:
None